HCQ Effective for COVID-19 in Small Randomized Trial

]]>(MedPage Today) -- Hospitalized patients in China with COVID-19 coronavirus treated with hydroxychloroquine (HCQ), an antimalarial also used to treat autoimmune diseases, had a shorter time to clinical recovery, as well as improved pneumonia, a...